BodyGuardian monitoring after AF ablation
Part of Heart & circulation clinical trials.
This study tests using a portable heart monitor called BodyGuardian to check for atrial fibrillation returning after a procedure called ablation. It may help your doctor find irregular heartbeats early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be eligible for and agree to join the main DISRUPT-AF study.
- You must agree to wear the BodyGuardian heart monitor after your ablation procedure.
- You must be willing to fill out a survey about your experience (the BOUNCE AF survey).
- You cannot have a known allergy to adhesives that might prevent you from wearing the monitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a remote monitor to check your heart rhythm after a catheter ablation is safe and helps detect irregular heartbeats early. You would use a small device at home to send your heart data to your care team.
This study tests whether a smartwatch can accurately track atrial fibrillation episodes after a catheter ablation procedure. It aims to provide a convenient way to monitor your heart rhythm without frequent clinic visits.
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
This trial tests a blood pressure monitor that can also detect atrial fibrillation (an irregular heartbeat). You may join if you are 22 or older, have an average-sized arm, and either have been diagnosed with AF or have never had it — as long as you don't have a pacemaker or defibrillator.
This study tests whether a special blood pressure monitor can detect atrial fibrillation, an irregular heartbeat that can increase stroke risk. It may help identify the condition early so you can get proper care.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.